| Application no. and date | 20729203.8 (espacenet) (Federated) (European Patent Register), 20200520 | | Patent/reg. no. and date | DK/EP 3972603, 20240904 | | Publication date | 20220330 | | Priority no. and date | US 201962851994 P, 20190523 | | EP pub. no. and date |
EP 3972603 20220330 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 170407/SH/CB | | Inventor | BHATTACHARYA, Souvik, Novartis Institutes for BioMedical Research, Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
BIETH, Bruno, Novartis Pharma AG Postfach
4002 Basel, CH,
CABANSKI, Maciej, Novartis Pharma AG Postfach
4002 Basel, CH,
CENNI, Bruno, Novartis Pharma AG Postfach Novartis Institutes
for Biomed. Research
4002 Basel, CH,
DE BUCK, Stefan, Novartis Pharma AG Postfach
4002 Basel, CH,
KAUL, Martin, Novartis Pharma AG Postfach Novartis Institutes
for Biomed. Research
4002 Basel, CH,
KINHIKAR, Arvind, Novartis Institutes for BioMedical Research, Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
RADIVOJEVIC, Andrijana, Novartis Pharmaceuticals Corporation 1 Health
Plaza
East Hanover, New Jersey 07936, US,
VITALITI GARAMI, Alessandra, Novartis Pharma AG Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 37/00 (2006.01) | | Title | Fremgangsmåder til behandling af Sjögrens Syndrom ved brug af en Brutons Tyrosinkinasehæmmer | | Int. application no. | IB2020054754 | | Int. publication no. | WO2020234781 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
